CP-724,714

A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called ErbB receptor tyrosine kinase inhibitors.

Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor del receptor ErbB de la tirosina cinasa.